The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFair Oaks Inc21 Regulatory News (FAIR)

Share Price Information for Fair Oaks Inc21 (FAIR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.565
Bid: 0.555
Ask: 0.575
Change: -0.005 (-0.88%)
Spread: 0.02 (3.604%)
Open: 0.565
High: 0.575
Low: 0.565
Prev. Close: 0.57
FAIR Live PriceLast checked at -
Fair Oaks Income 2017 is an Investment Trust

To generate attractive, risk-adjusted returns, principally through income distributions, mainly invests in US and European CLOs or other vehicles.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Distribution Policy

20 Sep 2022 07:00

RNS Number : 9226Z
Fair Oaks Income Limited
20 September 2022
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 which forms part of domestic law in the United Kingdom pursuant to The European Union (Withdrawal) Act 2018, as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019

 

20 September 2022

FAIR OAKS INCOME LIMITED(the "Company")

(Incorporated in Guernsey under The Companies (Guernsey) Law, 2008, as amended, with registered number 58123 and registered as a Registered Closed-ended Collective Investment Scheme with the Guernsey Financial Services Commission)

 

Distribution Policy

The Board announces that it has resolved to enhance the Company's aggregate distributions to holders of the 2021 Shares, with the objective of being meaningfully accretive to 2021 Shareholders and positively influencing the discount to NAV and trading liquidity of the 2021 Shares.

The Board has authorised:

· Share buyback programme. The Board has resolved to commence buybacks of 2021 Shares in the secondary market, initially for aggregate consideration of up to $20 million (equivalent to c.47 million shares at current mid-market price) funded from the Company's current material cash balance. It is also intended that buybacks will be used by the Company on an ongoing basis, subject to the level of the prevailing price relative to NAV.

 

· Dividend guidance and additional resource for buyback programme. The Board considers that, in addition to deploying current cash to the buyback programme, it will be accretive to 2021 Shareholder value, for as long as the discount to NAV remains wide, to direct a portion of net income into funding share buybacks rather than fully distributing as dividend. The Board therefore guides that it intends to declare future quarterly dividends on the 2021 Shares at a consistent rate of 2 US cents, equivalent to an annual dividend yield of 17% on the current price, with any excess net income available to fund share buybacks. Establishing a consistent level of dividend provides greater certainty about future income for existing and prospective shareholders; based on the last quarter's portfolio cashflows the 2 US cents quarterly dividend would have been healthily covered.

The Board and Investment Adviser believe that recent movements in the market price of the 2021 Shares are not being driven by fundamentals and intend through these measures to demonstrate the Company's capital discipline and confidence in the Company's cashflows and NAV. The effectiveness of the Company's evolved distribution policy will be closely monitored and the Company will update shareholders in due course.

 

Enquiries:

 

Fair Oaks Income Limited

Email: contact@fairoaksincome.com

Web: www.fairoaksincome.com

 

Fair Oaks Capital Limited

Investor Relations

DDI: +44 (0) 20 3034 0400

Email: ir@fairoakscap.com

 

Sanne Fund Services (Guernsey) Limited

Ben Le Prevost

DDI: +44 (0) 1481 755524

Email: Ben.LePrevost@sannegroup.com

 

Numis Securities Limited

Nathan Brown / Matt Goss, Investment Banking

DDI: +44 (0) 20 7260 1426/1642

Email: n.brown@numis.com / m.goss@numis.com

 

Liberum Capital Limited

Chris Clarke, Investment Banking

DDI: +44 (0) 20 3100 2190

Email: chris.clarke@liberum.com

LEI: 2138008KETEC1WM5YP90

Notes

As at 31 August 2022, the cash held in respect of the 2021 Shares was c.$27.1 million. This cash balance is pro-forma for the dividend announced in August 2022 and excludes proportional ownership of cash at the underlying Master Funds.

The Board retains absolute discretion as to the execution, pricing and timing of any share buybacks, subject to the conditions set out in the authority to execute share buybacks granted approved at the Company's 2022 annual general meeting. In accordance with that authority the maximum price paid in respect of any share buyback will be 105% of the average middle-market price for the five business days immediately before the purchase. Any shares purchased by the Company will be held in treasury.

Shareholders should be aware that a repurchase of shares on any trading day may represent a significant proportion of the daily trading volume in the shares and could exceed 25 per cent of the average daily trading volume of the preceding 20 business days.

The dividend guidance contained within this announcement represents guidance only and not a profit forecast. This guidance should not be taken as an indication of the Company's expected or actual current or future results and there can be no assurance that the level of dividend indicated will be paid.

Fair Oaks Income Limited

 

Fair Oaks Income Limited is a registered closed-ended investment company incorporated in Guernsey. The Company was admitted to trading on the Specialist Fund Market of the London Stock Exchange (now the Specialist Fund Segment of the Main Market of the London Stock Exchange) on 12 June 2014.

 

The investment policy of the Company is to invest (either directly and/or indirectly through FOIF II LP and FOMC III LP) in US and European CLOs or other vehicles and structures which provide exposure to portfolios consisting primarily of US and European floating-rate senior secured loans and which may include non-recourse financing.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEALNNFALAEFA
Date   Source Headline
25th Apr 20243:53 pmRNSNotice of AGM
22nd Apr 20249:24 amRNSDirectorate Change
19th Apr 20247:00 amRNSAnnual Financial Report
17th Apr 20247:00 amRNSNet Asset Value(s)
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20249:54 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 202411:00 amRNSDividend Currency Election
14th Mar 20247:00 amRNSNet Asset Value(s)
1st Mar 202410:36 amRNSTotal Voting Rights
29th Feb 20247:30 amRNSIssue of Treasury Shares
22nd Feb 20247:00 amRNSDividend Declaration
21st Feb 20247:00 amRNSNet Asset Value(s)
1st Feb 20247:02 amRNSReinvestment of Management Fees
1st Feb 20247:00 amRNSTotal Voting Rights
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSNet Asset Value(s)
11th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20242:39 pmRNSDirectorate Change
2nd Jan 202410:12 amRNSTotal Voting Rights
2nd Jan 20247:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20234:53 pmRNSVoting Rights and Capital
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20237:00 amRNSNet Asset Value(s)
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
8th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20235:07 pmRNSReturn of Capital to Realisation Shareholders
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20234:31 pmRNSReturn of Capital to Realisation Shareholders
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20234:14 pmRNSDividend Currency Election
5th Dec 20237:22 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.